Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease | Zendy

Heejin Yoo | Zendy; Yoon | Zendy; Hee Soon Chung | Zendy; Kim | Zendy; JungWon Park | Zendy; Yim | Zendy; Kwang–Hyub Han | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease

Author(s) -

Heejin Yoo,

Yoon,

Hee Soon Chung,

Kim,

JungWon Park,

Yim,

Kwang–Hyub Han

Publication year - 2013

Publication title -

international journal of copd

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 67

eISSN - 1178-2005

pISSN - 1176-9106

DOI - 10.2147/copd.s41749

Subject(s) - medicine , pulmonary disease , levofloxacin , cefuroxime , copd , intensive care medicine , disease , antibiotics , microbiology and biotechnology , biology

Antibiotic treatment is one of the major pharmacologic treatments for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). However, the choice of antibiotic depends on the local resistance pattern. A multicenter, randomized, controlled trial was done in patients with AECOPD to compare the efficacy of levofloxacin with that of cefuroxime axetil.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research